Triasima Portfolio Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
BCM
Triasima Portfolio Management's RGEN Position: Q3 2024 in Review
Triasima Portfolio Management sold out of Repligen (RGEN) in Q3 2024, closing a stake of 6,645 shares — an estimated $838K sold.
Triasima Portfolio Management first reported a position in RGEN in Q1 2024 and held it in 2 quarters. The position peaked at $1.22M in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.
- Triasima Portfolio Management reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
- Triasima Portfolio Management sold 6,645 Repligen shares in Q3 2024, an estimated $838K.
- Triasima Portfolio Management first reported a position in Repligen in Q1 2024 and held it in 2 quarters.
- Triasima Portfolio Management's Repligen position peaked at $1.22M in Q1 2024.
- 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.
Based on Triasima Portfolio Management's 13F filing for Q3 2024, filed 12 Nov 2024.